Skip to main content

Spaventa Andrew's Form 4 filing

Singular Genomics Systems, Inc.OMIC · filed Feb 14, 2025

Accession no.
0000950170-25-021402
Filed
Feb 14, 2025
Trade date
Feb 12-14, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $15.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Spaventa AndrewCIK 0001859701Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 12, 2025Common StockMOption exerciseAcquired+1,907–F1–2,232Direct
Feb 14, 2025Common StockSSaleDisposed−800$19.89F3−$15,9121,432Direct
Feb 14, 2025Common StockGGiftDisposed−1,107$0.00$0325Direct
Feb 14, 2025Common StockGGiftAcquired+1,107$0.00$0142,900Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 12, 2025Common StockMOption exerciseDisposed−1,907$0.00$022,873Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Referenced by the price of 1 transaction in Table I.

F3

Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.88 to $19.91, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)